Table 1.
Entry | Compound ID | R1 | R2 | Yield | EC50 (μM)a |
---|---|---|---|---|---|
1 | 14a | 80% | >100 | ||
2 | 14b | 85% | >100 | ||
3 | 14c | 65% | >100 | ||
4 | 14d | 80% | 8.95 | ||
5 | 14e | 58% | >100 | ||
6 | 14f | 80% | >100 | ||
7 | 14g | 67% | >100 | ||
8 | 14h | 48% | >100 | ||
9 | 14i | 30% | >100 | ||
10 | 14j | 73% | >100 | ||
11 | 14k | 55% | >100 | ||
12 | 14l | 56% | >100 | ||
13 | 14m | 85% | >100 | ||
14 | 14n | 80% | 9.45 | ||
15 | 14o | 57% | >100 | ||
16 | 14p | 51% | >100 | ||
17 | 14q | 50% | 9.45 | ||
18 | 14r | 60% | >100 |
Concentration required to reduce virus-induced cytopathogenicity by 50%.